Copenhagen, Denmark
Summary
This biopharmaceutical company utilizes a proprietary technology platform to develop innovative therapies aimed at addressing unmet medical needs in endocrinology and oncology. The company is focused on creating best-in-class treatments for rare diseases and is committed to making a significant impact on the lives of patients, caregivers, and healthcare professionals through its clinical pipeline and corporate responsibility initiatives.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
17.0 years — Since Jan 2008
Web Hosting
Platform
E-Mail Provider
Microsoft Office 365
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Biopharmaceuticals
2. Pharmaceutical Preparation Manufacturing
Vendor
Source
Microsoft
TXT Record
TXT Record
Miro
TXT Record
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
|
2011 |
|
|
|
|
|
|
|
|
|
|
|
|
2012 |
|
|
|
|
|
|
|
|
|
|
|
|
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
2018 |
|
|
|
|
|
|
|
|
|
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|